Common Contracts
11 similar Registration Rights Agreement contracts by Agilon Health, Inc., Virios Therapeutics, Inc., Capstone Therapeutics Corp., others
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 7th, 2024 • Virios Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is dated as of October 7, 2024, by and between Virios Therapeutics, Inc., a Delaware corporation (the “Company”), and Sealbond Limited, a British Virgin Islands corporation (“Sealbond”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 7th, 2024 • Virios Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is dated as of October 7, 2024, by and between Virios Therapeutics, Inc., a Delaware corporation (the “Company”), and Sealbond Limited, a British Virgin Islands corporation (“Sealbond”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 31st, 2024 • TRxADE HEALTH, INC • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
This Registration Rights Agreement (this “Agreement”) is dated as of ____________, 2024, by and among TRxADE Health, Inc., a Delaware corporation (the “Company”), and the several former stockholders of Scienture, Inc. signatory hereto (each, including its successors and assigns, a “Holder” and collectively, the “Holders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 22nd, 2023 • New York
NOTE: With thanks to the National Venture Capital Association upon whose form Investor Rights Agreement many of the provisions herein rely.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 4th, 2023 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made as of May 3, 2023 by and among Stoke Therapeutics, Inc. a Delaware corporation (the “Company”), and the persons listed on the attached Schedule A who are signatories to this Agreement (collectively, the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.
SERIES A-1 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 28th, 2021 • Crush Capital Inc. • Services-motion picture & video tape production • Delaware
This SERIES A-1 REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of June 14, 2021, by and among Crush Capital Inc., a Delaware corporation (the “Company”) and the shareholders listed on Schedule A hereto (the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 18th, 2021 • Agilon Health, Inc. • Services-misc health & allied services, nec • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of January 4, 2019, by and among Agilon Health Topco, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 18th, 2021 • Agilon Health, Inc. • Services-misc health & allied services, nec • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the 7th day of November, 2018, by and among Agilon Health Topco, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, acting by and through one of Morgan Stanley Investment Management Inc. or Morgan Stanley Investment Management Ltd., as agent and investment adviser to the Investors (each, an “Agent”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 1st, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of January 31, 2019, by and among Egalet Corporation, a Delaware corporation (the “Company”), and Iroko Pharmaceuticals Inc., a business company incorporated in the British Virgin Islands (registration number 1732699) (the “Stockholder”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 15th, 2017 • Neothetics, Inc. • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of November 25, 2015, by and among Evofem Holdings, Inc., a Delaware corporation (the “Company”) and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 26th, 2016 • Capstone Therapeutics Corp. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the 25th day of August, 2016, by and among LipimetiX Development, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Common Holder” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 3.9 hereof.
